Introduction
============

Over the last decade, synthetic biology has emerged as a powerful tool for biotechnology and basic science research ([@B5]). Coupled with rapidly improving DNA synthesis technologies, one of the key advances that has potentiated the rapid expansion of synthetic biology is new DNA assembly technologies ([@B16]). The ability for synthetic biologists to rapidly assemble and test new designs at low cost is invaluable to progress in a wide-range of life sciences research. Applications for this range from investigating new antibody production with higher success rates, to increased food production minimizing the carbon footprint with the effective transfer of nitrogen fixation between bacterial species ([@B28]).

Golden Gate cloning is a DNA assembly technology that utilizes type IIS restriction enzymes to assemble multiple fragments of DNA in a linear order ([@B31]). Since type IIS restriction endonucleases cleave outside of their recognition site, the nucleotides in the cut-site of the enzyme are not discriminated and can be tailored to suit. This permits assembly of multiple fragments of DNA in a directional, linear order by using unique cut/ligation sites between each fragment, all of which can be cut by the same type IIS restriction enzyme. The two most commonly used Golden Gate enzymes are BsaI and BpiI, each has a 6 base-pair (bp) recognition site and a 4 bp sticky-end cut site ([@B31]). The ability of these enzymes to cleave outside of their recognition site and careful design of compatible overhanging sequences allows repeated rounds of cutting followed by ligation to proceed toward a stable product which remains undigested because it lacks enzyme recognition sites (due to the inward orientation of the type IIS recognition sites at the far 5′ and 3′ ends of modules) ([@B7]). This approach has given a massive improvement in the efficiency of assembly compared to traditional rounds of restriction/ligation cloning and has been used to assemble at least nine fragments in linear order, with 90% of transformed bacterial colonies containing correct products ([@B7]).

Golden Gate cloning platforms have been developed for plants, fungi and the bacterium *Escherichia coli* ([@B9]; [@B29]; [@B1]; [@B19]). However, in a wide-range of bacteria, vectors for cloning using Golden Gate tools are not available. The ability to use the most up-to-date molecular tools will be crucially important for the future agricultural biotechnology required to feed a growing population. Here, we describe the development of a system for modular assembly of Golden Gate-compatible cloning broadhost range vectors from a library of vector parts. Vectors are assembled in *E. coli* and can be transferred easily to other bacterial species by conjugation. A key advantage of the tool kit described herein is the development of Golden Gate compatible plasmids with broad host range for use in Gram-negative bacteria phylogenetically distinct from *E. coli*. We demonstrate the efficacy of this system by constructing several vectors, analogous to useful traditional cloning broad-host range vectors but that are now Golden Gate-compatible: level 1 cloning broad-host range vectors pOGG024, a medium copy plasmid for bacterial gene, and pOGG026, a low copy number vector for gene expression in environmental samples where no antibiotic selection is applied. We also describe the construction through this modular vector system of a level 2 broad-host range vector pOGG216.

Results and Discussion
======================

Modular Vector Assembly
-----------------------

A new standardized system for vector assembly was designed based on Golden Gate cloning and the MoClo system described by [@B31]. To describe cloning into vectors constructed by this system we maintain the defined hierarchical assembly language in MoClo. "Level 0" refers to base parts that make up an open reading frame (ORF; ex: promoter, coding sequence, and terminator), "level 1" refers to a single ORF made up of level 0 parts, and "level 2" refers to several ORFs organized together ([@B31]). Level 1 cloning describes assembly of level 0 parts into an ORF using the enzyme BsaI. Level 2 cloning describes assembly of level 1 ORFs into a multi-gene construct using BpiI. A level 1 cloning vector is used for assembly of a single ORF by level 1 cloning. A level 2 cloning vector is used for the assembly of multiple ORFs together by level 2 cloning ([@B31]).

We have designed the bacterial vector assembly system with a series of discrete key modules. In order to do this, we took advantage of the modularization and miniaturization of bacterial vector modules in the Standard European Vector Architecture (SEVA) ([@B27]; [@B18]). In SEVA, these modules are arranged in a predefined order and assembled using standard restriction enzymes and standard restriction/ligation reactions. We have conserved this organization in the modular vector assembly system: position 1 is the cloning site(s), position 2 is the antibiotic resistance cassette, position 3 is origins of replication and transfer. Three more positions (4 to 6) have been reserved for additional accessory modules for specific applications. Endlinkers containing terminators (ELT) are used to circularize the plasmid by connecting the final position used to position 1 (Figure [1A](#F1){ref-type="fig"}). We incorporated Golden Gate level 1 and level 2 cloning sites into position 1 to make them compatible with the MoClo Golden Gate cloning system (Figure [1B](#F1){ref-type="fig"}). Each vector construction module is flanked with inward-facing recognition sites for the type IIS restriction enzyme Esp3I and the cut sites, giving overhangs with sequences specific for each module (fusion sites shown in Table [1](#T1){ref-type="table"}), allow directional linear assembly in a one-pot reaction such as used in Golden Gate cloning ([@B31]).

![Bacterial Expression Vector Archive (BEVA) system for the modular assembly of bacterial vectors. **(A)** Vector modules are shown in the order they are assembled in a vector construction reaction. Their position in the final construct is labeled. Sequences (5′→ 3′) used to anneal the fragments in order are shown (color-coded) at junctions between modules and remain in the final construct as a scar. **(B)** Modules at each position. Position 1: cloning sites -- Golden Gate level 1 and Golden Gate level 2; position 2: antibiotic resistance -- neomycin-, gentamicin- and tetracycline-resistance cassettes; position 3: origins of replication and transfer -- RK2 with *oriT* and pBBR1 with *oriT*; positions 4--6: accessory modules -- *par* locus for stable plasmid maintenance in the absence of antibiotic selection. Endlinker modules were designed to circularize the plasmid.](fmicb-09-03345-g001){#F1}

###### 

Design of modules for vector construction.

  Module                                                Description of module                                                                                      Module size (kb)   Cloned module   5′-side (5′→3′)   3′-side (5′→3′)
  ----------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------ --------------- ----------------- -----------------
  **Position 1: cloning sites**                                                                                                                                                       TGCC            GCAA              
  pLVC-P1-Lv1                                           Golden Gate Level 1 cloning site with cloned *lacZ*                                                        2601               pOGG004                           
                                                        Golden Gate Level 1 cloning site                                                                           2420               pOGG005                           
  pLVC-P1-Lv2                                           Golden Gate Level 2 cloning site                                                                           5729               pOGG006                           
  **Position 2: antibiotic resistance**                                                                                                                                               GCAA            ACTA              
  pLVC-P2-neo                                           Neomycin/kanamycin-resistance                                                                              936                pOGG008                           
  pLVC-P2-gent                                          Gentamicin-resistance                                                                                      813                pOGG009                           
  pLVC-P2-tet                                           Tetracycline-resistance                                                                                    1964               pOGG042                           
  **Position 3: origins of replication and transfer**                                                                                                                                 ACTA            TTAC              
  pLVC-P3-RK2                                           RK2 (IncP) origin of replication for low copy number plasmid, *oriT* from *E. coli* for plasmid transfer   2485               pOGG010                           
  pLVC-P3-pBBR1                                         pBBR1 origin of replication for medium copy number plasmid, *oriT* from *E. coli* for plasmid transfer     1784               pOGG011                           
  **Position 4: accessory**                                                                                                                                                           TTAC            CAGA              
  pLVC-P4-par                                           Partition genes (*parABCDE*) for plasmid stability in absence of antibiotic selection                      2408               pOGG012                           
  **Position 5: accessory**                                                                                                                                                           CAGA            TGTG              
  **Position 6: accessory**                                                                                                                                                           TGTG            GAGC              
  **Endlinker**                                                                                                                                                                                                         
  pLVC-ELT-3                                            Endlinker to circularize plasmid after position 3                                                          113                pOGG013         TTAC              TGCC
  pLVC-ELT-4                                            Endlinker to circularize plasmid after position 4                                                          113                pOGG014         CAGA              TGCC
  pLVC-ELT-5                                            Endlinker to circularize plasmid after position 5                                                          113                pOGG015         TGTG              TGCC
  pLVC-ELT-6                                            Endlinker to circularize plasmid after position 6                                                          113                pOGG016         GAGC              TGCC

Vector Module Design
--------------------

Modules at each position (1 to 6 and Endlinkers, Table [1](#T1){ref-type="table"}) have inward-facing Esp3I sites which on digestion give 4 bp-overhangs. These overhangs are able to anneal with those from neighboring modules in a linear fashion and, on vector assembly, give 4 bp motifs which remain at the join between modules (all motifs for each junction are listed in Table [1](#T1){ref-type="table"} and Figure [1](#F1){ref-type="fig"}). An advantage of modular assembly is the ability to utilize minimal parts which exclude any non-functional DNA. This allows construction of vectors with the same key features as those currently widely adopted, but the resulting plasmid is significantly smaller in size. The reduced size enhances the ease of DNA manipulation and allows accommodation of larger cloned inserts. To this end, several modules (positions 2 and 3) used the minimal units of antibiotic-resistance modules and origins of replication/transfer previously defined by SEVA ([@B27]; [@B18]; Table [1](#T1){ref-type="table"}).

Most parts were constructed by DNA synthesis by Invitrogen and supplied in the GeneArt cloning vector pMS (Invitrogen, Thermo Fisher Scientific Inc.). As an alternative, some vector modules were constructed by PCR amplification from commonly used vectors (see Table [2](#T2){ref-type="table"}). In several cases, this was a cheaper and faster option than the synthesis of the DNA fragments. Modules synthesized by Invitrogen were domesticated prior to DNA synthesis by removal of BsaI, BpiI, DraIII, and Esp3I (Golden Gate cloning restriction enzyme sites) by altering a single nucleotide in the recognition site. In an ORF, a neutral change was made in the wobble base of a codon, such that the same amino acid was encoded. Outside of an ORF, a transition mutation was introduced.

###### 

Level 0 modules for cloning in a Level 1 vector.

  Module                                                  Description of module                                                                   Module size (bp)   Cloned module   5′-side (5′ → 3′)   3′-side (5′ → 3′)
  ------------------------------------------------------- --------------------------------------------------------------------------------------- ------------------ --------------- ------------------- -------------------
  **PU modules: promoters with ribosome-binding sites**                                                                                                              GGAG            AATG                
  pL0M-PU-pNeo                                            Promoter upstream of *nptII* for constitutive gene expression                           386                pOGG001                             
  pL0M-PU-pT7lacO                                         IPTG-inducible T7RNAP promoter                                                          95                 pOGG030                             
  pL0M-PU-pLac                                            IPTG-inducible promoter                                                                 258                pOGG031                             
  pL0M-PU-pTau                                            Taurine-inducible promoter for Alphaproteobacteria                                      1811               pOGG041                             
  pL0M-PU-pNifH                                           Promoter upstream of *nifH* for nodule-specific gene expression in *R. leguminosarum*   721                pOGG082                             
  **SC modules: ORFs**                                                                                                                                               AATG            GCTT                
  pL0M-SC-mCherry                                         Red fluorescence protein mCherry, reporter of gene expression                           716                EC15071                             
  pL0M-SC-sfGFP                                           Superfolder GFP, stable and bright reporter of gene expression                          722                pOGG037                             
  pL0M-SC-celB                                            Thermostable beta-galactosidase, reporter of gene expression                            1424               pOGG050                             
  pL0M-SC-gusA                                            Beta-glucosidase gene, reporter of gene expression                                      1817               pOGG083                             
  **T modules: terminators**                                                                                                                                         GCTT            CGCT                
  pL0M-T-pharma                                           Pharmacia terminator (Invitrogen)                                                       188                pOGG003                             
  pL0M-T-T7                                               Terminator for T7RNAP                                                                   55                 pOGG039                             

All modules were supplied cloned in Sp

r

plasmid pMS except for pOGG082 and pOGG083. Following BsaI digestion of cloned modules and a Level 1 vector, the resulting overhangs are used to anneal the fragments in a linear fashion and the sequences shown remain between modules upon ligation

.

The position 1 modules we designed are based on level 1 and level 2 cloning sites pL1F-1 and pL2V-1 from the MoClo system of [@B31] (Table [1](#T1){ref-type="table"}). The level 1 cloning site in pOGG004 contains a *lacZα* fragment that is replaced following Golden Gate cloning in the MoClo system, resulting in blue to white colony color selection when plated on appropriate media. Since *lacZα* still contains a polylinker, vectors constructed with the level 1 Golden Gate cloning site are also flexible for use in traditional cloning utilizing unique restriction sites in the polylinker and blue-white selection. The level 2 Golden Gate cloning site encodes a canthaxanthin biosynthesis operon that is replaced upon successful level 2 cloning resulting in a transition from an orange colony color to white or blue. Both position 1 modules (level 1 and level 2 cloning sites) include a *rho*-independent T~0~ lambda phage transcription terminator ([@B17]) included at their 3′-end.

We note that the level 1 Golden Gate cloning site part (pOGG004) is maintained in a high copy number vector backbone suitable for recombinant protein production in *E. coli*. Thus it can be utilized as a level 1 cloning vector for this purpose. To expand this utility we also synthesized a version with an ampiciliin-resistant backbone (pOGG005).

For position 2 (antibiotic resistance), gentamicin- and neomycin-resistance modules were based on the minimal resistance cassettes from SEVA ([@B27]). The 5′-end SwaI and 3′-end PshAI sites that flanked the SEVA modules were replaced with inward-facing Esp3I sites. We found that the SEVA constitutive *tetA* gene conferred insufficient levels of tetracycline resistance to our organisms of interest (data not shown), therefore we designed a more robust tetracycline-resistance module based on the *tetAR* resistance module from pJP2 ([@B22]). To preserve a minimal size, only DNA between the stop codons of the divergently transcribed *tetA* and *tetR* was used and their orientation conserved (Figure [1B](#F1){ref-type="fig"}). In position 3 (origins of replication and transfer), modules containing pBBR1 and RK2 origins of replication were designed based on SEVA modules ([@B27]), but with inward-facing Esp3I sites replacing PshAI and AscI sites. An origin of transfer (*oriT*), to permit conjugation from *E. coli* into target strains, was included at the 5′-end. At position 4, an accessory module for stable plasmid maintenance in the absence of antibiotic selection was designed. Based on the *par* locus from pJP2, which has previously been shown to render stable plasmid maintenance in the absence of antibiotic selection ([@B22]), *parABCDE*, as well as 107 bp downstream of *parE* (at 5′-end) and 139 bp downstream of *parA* (at 3′-end) (Figure [1B](#F1){ref-type="fig"}) was oriented such that the *parE* was transcribed toward position 3, while *parA* was at the 3′-end, transcribed toward position 1 (Figure [1B](#F1){ref-type="fig"}).

Endlinker (ELT) modules were designed to complete assembly by circularizing the plasmid, either by linking position 3 (origin of replication), or accessory modules at positions 4, 5, or 6 to position 1 (cloning sites). Endlinker modules contain the *E. coli* T~1~ *rrnBT1* terminator to help buffer any transcription effects from the cloning site ([@B17]).

Design and Construction of Level 0 Open Reading Frame Parts
-----------------------------------------------------------

Golden Gate cloning is often used in a hierarchical assembly where level 0 parts (genetic features controlling a gene's transcription, translation and the termination of transcription) are assembled in a single one-pot reaction wherein parts are added as plasmids together with restriction enzyme and ligase in a single tube (referred to as level 1 assembly) allowing directional linear assembly ([@B31]). In order to test the vectors that we constructed, we adapted several parts that are routinely used in our lab, including promoters with ribosome binding sites (PU modules -- **p**romoter and **u**ntranslated region), ORFs (SC modules -- **s**ignal and **c**oding sequence) and a terminator (T module). These parts were synthesized as described for vector construction modules, except that they were assembled with inward-facing BsaI sites that cut appropriate sequences for level 1 assembly (Table [2](#T2){ref-type="table"}).

We adapted several promoters routinely used for gene expression in rhizobia or *E. coli* for use as PU modules (Table [2](#T2){ref-type="table"}). These are the constitutive neomycin cassette promoter (pNptII) ([@B11]) T7RNAP promoter repressible by LacI (pT7lacO) ([@B3]), the Lac promoter from *E. coli* (*pLac*) ([@B15]), the taurine-inducible promoter of *S. meliloti* (*pTau*) ([@B30]) and the symbiosis-induced *nifH* promoter from *Rhizobium leguminosarum* biovar *viciae* 3841 (Rlv3841P*nifH*) ([@B14]). For all promoters, the nucleotide immediately upstream of the ATG was domesticated to an A to construct the 5′-AATG-3′ cut-site such that the ATG encodes the start codon of the ORF to be expressed.

For SC modules (Table [2](#T2){ref-type="table"}), we utilized several different reporter genes to demonstrate vector function. These include genes encoding superfolder green fluorescent protein (sfGFP) ([@B20]), *E. coli* β-glucuronidase (*gusA*) and *Pyrococcus furiosus* thermostable β-glucosidase/ β-galactosidase (*celB*) ([@B26]; [@B24]). Domestication and gene synthesis were used to produce SC modules of sfGFP and *celB*, and *gusA*. All SC modules were constructed flanked by inward facing BsaI restriction site cutting 5′-AATG-3′ at the 5′ end and GCTT at the 3′ end. In all cases the final three nucleotides of the AATG scar encode the start codon for the ORF and the GCTT scar immediately follows the stop codon.

For use as a transcriptional terminator, the *rrnBT1* transcriptional terminator with flanking regions from pLMB509 ([@B30]) (9 bp upstream and 84 bp downstream) were synthesized and flanked by BsaI sites cutting GCTT and CGCT on the 5′ and 3′ of the ORF. All the novel BEVA parts, vectors and plasmids are available through Addgene (Addgene ID^[1](#fn01){ref-type="fn"}^ is shown in Table [3](#T3){ref-type="table"}).

###### 

Strains, plasmids, and primers used in this study.

  Strain, plasmid or primer              Description                                                                                                                                                                                                               Source or reference            Addgene ID
  -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ ------------
  **Strain**                                                                                                                                                                                                                                                                                      
  *E. coli* strains                                                                                                                                                                                                                                                                               
  α-Select Gold                          Competent cells. Genotype: F -- deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-, mk + ) supE44 thi-1 phoA Δ(lacZYA argF)U169 Φ80lacZΔM15λ -                                                                                      Bioline                        
  DH5α                                   Competent cells. Genotype: F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ-                                                                                              Invitrogen                     
  *R. leguminosarum* bv. *viciae* 3841   *Rhizobium leguminosarum* bv. *viciae*, derivative of strain 300, Str^r^                                                                                                                                                  [@B14]                         
  *Rhizobium tropici* CIAT899            *Rhizobium tropici*, Rf^r^                                                                                                                                                                                                [@B13]                         
  **Plasmid**                                                                                                                                                                                                                                                                                     
  pJP2                                   pTR102 GUS with artificial MCS, Amp^r^ Tet^r^                                                                                                                                                                             [@B22]                         
  EC15071                                pL0M-SC-mCherry. Level 0 SC module cloned in pMS, Sp^r^                                                                                                                                                                   ENSA, supplied by Invitrogen   
  pMS                                    Vector with ColE1 origin of replication in which modules are supplied from Invitrogen, Sp^r^                                                                                                                              Invitrogen                     
  pLMB509                                Highly inducible His tag expression vector, Gm^r^                                                                                                                                                                         [@B30]                         40084
  pOGG001                                pL0M-PU-pNeo, promoter 379 bp upstream from of the start codon of luxC from pIJ11268 of nptII for constitutive gene expression. Level 0 PU module cloned in pMS, Sp^r^                                                    This study                     113978
  pOGG003                                pL0M-T-pharma. Level 0 T module cloned in pMS, Sp^r^                                                                                                                                                                      Invitrogen                     
  pOGG004                                pLVC-P1-Lv1 (Golden Gate Level 1 cloning site with cloned lacZ) position 1 module for vector construction cloned in pMS, Sp^r^                                                                                            This study                     113979
  pOGG005                                pL1V-Lv1-amp-ColE1, Level 1 cloning vector, high copy number used for protein expression in *E. coli*, Amp^r^                                                                                                             This study                     113980
  pOGG006                                pLVC-P1-Lv2, Golden Gate Level 2 cloning site, position 1 module for vector construction cloned in pMS, Sp^r^                                                                                                             This study                     113981
  pOGG008                                pLVC-P2-neo, neomycin-resistance gene, position 2 module for vector construction cloned in pMS, Spr Nm^r^/Kan^r^                                                                                                          This study                     113982
  pOGG009                                pLVC-P2-gent, gentamicin-resistance gene, position 2 module for vector construction cloned in pMS, Sp^r^ Gm^r^                                                                                                            This study                     113983
  pOGG010                                pLVC-P3-RK2, RK2 origin of replication and oriT from *E. coli*, position 3 module for vector construction cloned in pMS, Sp^r^                                                                                            This study                     113984
  pOGG011                                pLVC-P3-pBBR1, pBBR1 origin of replication and oriT from *E. coli*, position 3 module for vector construction cloned in pMS, Sp^r^                                                                                        This study                     113985
  pOGG012                                pLVC-P4-par, partition genes (parABCDE from pMS) for plasmid stability, position 4 module for vector construction cloned in pMS, Sp^r^                                                                                    This study                     113986
  pOGG013                                pLVC-ELT-3, connecting position 3 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Sp^r^                                                                                       This study                     113987
  pOGG014                                pLVC-ELT-4, connecting position 4 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Sp^r^                                                                                       This study                     113988
  pOGG015                                pLVC-ELT-5, connecting position 5 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Sp^r^                                                                                       This study                     113989
  pOGG016                                pLVC-ELT-6, connecting position 6 to position 1 to circulaise vector, endlinker module for vector construction cloned in pMS, Sp^r^                                                                                       This study                     113990
  pOGG021                                Destination vector for pL1V-F1, Amp^r^                                                                                                                                                                                    [@B31]                         
  pOGG024                                pL1V-Lv1-gent-pBBR1-ELT3, 3.4 kb, medium copy, broad-host range Level 1 cloning vector, Gm^r^                                                                                                                             This study                     113991
  pOGG026                                pL1V-Lv1-neo-RK2-par-ELT4, 6.6 kb, low copy, environmentally stable, broad-host range Level 1 cloning vector, Nm^r^/Kan^r^                                                                                                This study                     113992
  pOGG030                                pL0M-PU-pT7lacO, IPTG-inducible T7RNAP promoter 88 bp promoter and RBS driving recombinant protein expression in the pET and pOPIN vectors. Level 0 PU module cloned in pMS, Sp^r^                                        This study                     113993
  pOGG031                                pL0M-PU-pLac, IPTG-inducible promoter 250 bp immediately upstream of the lacZ alpha fragment start codon in pRK415. Level 0 PU module cloned in pMS, Sp^r^                                                                This study                     113994
  pOGG037                                pL0M-SC-sfGFP, pMS Level 0 SC module cloned in pMS, Sp^r^                                                                                                                                                                 This study                     113995
  pOGG039                                pL0M-T-T7. Level 0 T module cloned in pMS, Sp^r^                                                                                                                                                                          This study                     113996
  pOGG041                                pL0M-PU-pTau, Taurine-inducible promoter for Alphaproteobacteria, Level 0 PU module cloned in pMS, Sp^r^                                                                                                                  This study                     113997
  pOGG042                                pLVC-P2-tet, tetracycline-resistance gene (tetAR) from pJP2. Made by PCR using oxp0734 and oxp0735 primers in position 2 module for vector construction cloned in pMS, Sp^r^, Tet^r^                                      This study                     113998
  pOGG050                                pL0M-SC-celB. Level 0 SC module cloned in pMS, Sp^r^                                                                                                                                                                      This study                     113999
  pOGG054                                Destination vector for pL1V-F2, Amp^r^                                                                                                                                                                                    [@B31]                         
  pOGG056                                Destination vector for Level 2 Endlinker ELB-2, Amp^r^                                                                                                                                                                    [@B31]                         
  pOGG068                                Destination vector for pL0V-PU, Sp^r^                                                                                                                                                                                     [@B31]                         
  pOGG072                                Destination vector for pL0V-SC, Sp^r^                                                                                                                                                                                     [@B31]                         
  pOGG082                                pL0M-PU-*pNifH*, promoter 714 bp upstream of the ATG of *nifH* for nodule-specific gene expression in *R. leguminosarum.* Made by PCR using oxp0474 and oxp0475 primers and cloned in destination vector pOGG068, Sp^r^   This study                     114000
  pOGG083                                pL0M-SC-gusA, *gusA* gene from pJP2. Made by PCR using oxp0376 and oxp0377 primers and cloned in destination vector pOGG072. Sp^r^                                                                                        This study                     114001
  pOGG202                                pL1M-F1-plac (pOGG031), sfGFP (pOGG037) and T-pharma (pOGG003), Amp^r^                                                                                                                                                    This study                     115503
  pOGG203                                pL1M-F2-pNeo (pOGG001), mCherry (EC15071) and T-pharma (pOGG003), Amp^r^                                                                                                                                                  This study                     115504
  pOGG216                                pL2V-L2-tet-pBBR1-ELT3, 9.5 kb, medium copy, broad-host range. Level 2 cloning vector, Tet^r^                                                                                                                             This study                     114002
  pOPS0253                               Reporter plasmid constructed with Rlv3841P*nifH* (pOGG082), *gusA* (pOGG083) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                                    This study                     115505
  pOPS0254                               Reporter plasmid constructed with Rlv3841P*nifH* (pOGG082), *celB* (pOGG050) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                                    This study                     115506
  pOPS0314                               Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001), *celB* (pOGG050) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                        This study                     115507
  pOPS0359                               Reporter plasmid constructed with pTau (pOGG041), sfGFP (pOGG037) and T-pharma (pOGG003) assembled in pOGG024, Gm^r^                                                                                                      This study                     115508
  pOPS0377                               Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001), sfGFP (pOGG037) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                         This study                     115509
  pOPS0379                               Reporter plasmid constructed with Rlv3841P*nifH* (pOGG082) sfGFP (pOGG037) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                                      This study                     115510
  pOSP0750                               Reporter Plasmid constructed with constitutive promoter pNeo (pOGG001) *gusA* (pOGG083) and T-pharma (pOGG003) assembled in pOGG026, Nm^r^/Kan^r^                                                                         This study                     115511
  pOPS0754                               Dual reporter plasmid. Forward position 1 pOGG202, forward position 2 pOGG203 and level 2 Endlinker ELB-2 (pOGG056) assembled in pOGG216, Tet^r^                                                                          This study                     115512
  **Primer**                                                                                                                                                                                                                                                                                      
  oxp0376                                Forward primer for amplification of *gusA* gene for SC module. Sequence: CACTCTGTGGTCTCAAATGGTCCGTCCTGTAG                                                                                                                 This study                     
  oxp0377                                Reverse primer for amplification of *gusA* gene for SC module. Sequence: CACTTCGTGGTCTCAAAGCTCATTGTTTGCCTCCC                                                                                                              This study                     
  oxp0734                                Forward primer for amplification of tetracycline-resistance gene (tetAR) from pJP2. Used in position 2 module for vector construction. Sequence: TTTTGAAGACAAGAATACAGTCATAAGTGCGGC                                        This study                     
  oxp0735                                Reverse primer for amplification of tetracycline-resistance gene (tetAR) from pJP2. Used in position 2 module for vector construction. Sequence: TTTTTGAAGACAATGCCGGTCTCCATAACCGGA                                        This study                     
  oxp0474                                Forward primer for amplification of P*nifH* region of Rlv3841 plasmid pRL10 for PU module. Sequence: CACTCTGTGGTCTCAGGAGTCGATGCTGACCGCCT                                                                                  This study                     
  oxp0475                                Reverse primer for amplification of P*nifH* region of Rlv3841 plasmid pRL10 for PU module. Sequence: CACTTCGTGGTCTCACATTTTTGGCGTTCCTTCATGTGT                                                                              This study                     
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Vectors for Golden Gate Level 1 Cloning in Bacteria
---------------------------------------------------

Vector assembly reactions were performed by selecting appropriate modules in each position (Figure [1](#F1){ref-type="fig"}, summary of the sequences used to combine the modules which remain at their junctions and fusion sites are given in Table [1](#T1){ref-type="table"}).

To demonstrate the flexibility of the system, two vectors for level 1 cloning, analogous to those used for traditional cloning and DNA manipulation in Gram-negative bacteria, were constructed. Plasmid pOGG024 (Figure [2A](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}), a 3.4 kb level 1-compatible vector for bacterial gene expression, was made by adding the plasmids (listed in Table [3](#T3){ref-type="table"}) to a one-pot reaction (digestion with Esp3I and ligation) to combine the following modules: position 1; level 1 cloning site from pOGG004, position 2; gentamicin resistance cassette from pOGG009, position 3; pBBR1-based origin of replication from pOGG011 and the appropriate Endlinker (ELT3) from pOGG013 (Table [1](#T1){ref-type="table"}).

![**(A)** Schematic map of pOGG024 level 1 broad-host range, medium copy number vector constructed with BEVA for free-living gene expression in laboratory. **(B)** Schematic map of plasmid pOPS0359 containing a cloned gene sfGFP under the control of a taurine-inducible promoter from *Sinorhizobium meliloti* in pOGG024. **(C--F)** Evaluation of pOPS0359 performance as robust free-living gene expression compared to the functionally analogous pLMB509 plasmid. **(C,D)** Fluorescence detection from GFP expression and **(E,F)** fitness performance by measurement of OD~595~ when grown without (0 mM) or with (0.5, 1.0, 10, or 40 mM) taurine. For all graphs, error bars are standard error of the mean (SEM).](fmicb-09-03345-g002){#F2}

Plasmid pOGG026 (6.6 kb, Figure [3A](#F3){ref-type="fig"} and Table [3](#T3){ref-type="table"}) was constructed by combining the following modules (Table [2](#T2){ref-type="table"}) in a one-pot reaction (digestion with Esp3I and ligation): position 1; level 1 cloning site from pOGG004, position 2; neomycin resistance gene from pOGG008, position 3; RK2-based origin of replication from pOGG010, position 4; *parABCDE* genes which confer stability in the absence of antibiotics from pOGG012 and the appropriate Endlinker (ELT4) from pOGG014 (Table [1](#T1){ref-type="table"}).

![**(A)** Schematic map of pOGG026 level 1 broad-host range, lower copy number vector constructed with BEVA for stable environmental gene expression in the absence of antibiotic selection. **(B,C)** Schematic map of plasmids containing a cloned **(B)** *gusA* (pOPS0253) and **(C)** *celB* (pOPS0254) under the control of *nifH* gene promoter (P*nifH*). **(D)** Pea nodules formed by Rlv3841\[pOPS253\] stained with Magenta-glucA. Marker gene *gusA* is just expressed in nodules. **(E)** Pea nodules formed by Rlv3841\[pOPS254\] and **(F)** bean nodules formed by CIAT899\[pOPS254\] stained with X-gal after thermal treatment. Marker genes *gusA* and *celB* are just expressed in nodules.](fmicb-09-03345-g003){#F3}

Gene Expression Using Vector pOGG024
------------------------------------

In previous work, we described the construction of pLMB509 ([@B30]), a plasmid which has a taurine-inducible promoter upstream of a gene encoding GFP (*gfpmut3.1*). To evaluate the performance of vector pOGG024 through comparison with the fully-characterized pLMB509, we assembled plasmid pOPS0359 by cloning a taurine-inducible promoter upstream of superfolder GFP (sfGFP) to create a functionally analogous plasmid, i.e., taurine-inducible expression of GFP (Figure [2B](#F2){ref-type="fig"}). Taurine-dependent GFP expression of plasmids pOPS0359 and pLMB509 in a Rlv3841 background is shown in Figures [2C,D](#F2){ref-type="fig"}. Under conditions of 0 to 40 mM taurine they showed similar growth (Figures [2E,F](#F2){ref-type="fig"}) and gave fluorescence profiles indicating induction of GFP throughout the exponential phase. Although similar GFP induction profiles were seen, pOPS0359 showed significantly higher levels of overall fluorescence, especially at 10 and 40 mM taurine. As the plasmids share the same origin of replication (pBBR1) there are several factors that are likely to have had an influence on this; the brighter fluorescence of sfGFP ([@B20]) (pOPS0359) compared to that of GFPmut3.1 (pLMB509), and the reduced size of pOPS0359 (5.5 kb) compared to pLMB509 (6.8 kb) perhaps leading to an increased plasmid copy number. Alternatively, codon preference in the nucleotide sequence may have influenced expression levels as neither sequences was codon optimized for Rlv3841.

Gene Expression Using pOGG026
-----------------------------

To demonstrate the flexibility of BEVA we constructed a relatively low copy number, stable plasmid pOGG026, suitable for experiments in environments where there is no antibiotic selection present.

To demonstrate the stability of pOGG026, and therefore its use for experiments carried out in many different environments, it was used to construct plasmids pOPS0253 (Figure [3B](#F3){ref-type="fig"}), pOPS0254 (Figure [3C](#F3){ref-type="fig"}) and pOPS0379 (Figure [4A](#F4){ref-type="fig"}) by Golden Gate cloning. These plasmids were conjugated into *R. leguminosarum* Rlv3841 and used to inoculate peas. Plasmid pOPS0254 was also conjugated into R. *tropici* CIAT 899 ([@B13]) and used to inoculate bean plants. We did five biological replicates of all the inoculations.

![**(A)** Schematic map of plasmid pOPS0379 containing sfGFP gene under the control of *nifH* gene promoter (P*nifH*). Pea nodules formed by Rlv384\[pOPS0379\], **(B,C)** bright-field, **(D,E)** fluorescence (GFP filter), and **(F,G)** merged images. GFP expression is observed in the nitrogen-fixing zone.](fmicb-09-03345-g004){#F4}

The expression of the chromogenic marker genes in plasmids pOPS0253 and pOPS0254 can be followed by staining either pink (*gusA*) or blue (*celB*) when the appropriate substrate is supplied ([@B26]). Stained pea nodules are shown in Figures [3D,E](#F3){ref-type="fig"} and stained bean nodules are shown in Figure [3F](#F3){ref-type="fig"}. Figures [4B,C](#F4){ref-type="fig"} show pea nodules formed by Rlv3841\[pOPS0379\]. Figure [4B](#F4){ref-type="fig"} shows mature nodules 28 dpi and Figure [4C](#F4){ref-type="fig"} shows senescent nodules 42 dpi with the senescent area furthest from the tip. The inducible expression of sfGFP can be observed when nodules reach mature stage (Figure [4D](#F4){ref-type="fig"}) and just in the nitrogen fixing zone (Figures [4D--G](#F4){ref-type="fig"}). GFP fluorescence was not detected in senescent areas of nodules (Figure [4G](#F4){ref-type="fig"}).

In nodules plasmids are often lost and there is an inability to apply antibiotic selection to maintain those which have a plasmid-borne resistance cassette ([@B25]; [@B32]; [@B6]). In our assays, all mature nodules showed fluorescence or corresponding staining after enzymatic reaction with Magenta-glcA or X-gal, but to further verify plasmid stability, at least three nodules from each plant were removed, surface-sterilized and crushed into 100 μl sterile distilled water. Aliquots of each nodule extract were spotted onto TY agar plates. Afterward, eight independent colonies from each crushed nodule were screened for antibiotic resistance and all colonies showed neomycin resistance, corresponding to the plasmid vector pOGG026. In total at least 120 independent colonies from nodules were screened and none were detected that had lost the plasmid.

Using pOPS0253 and pOPS0254 we have developed a plasmid-based system that can be utilized for assessing competitiveness between rhizobia which is similar to the chromosomally encoded strategy described by [@B24]. We note that pOPS0379 could be used in a non-invasive symbiosis-induced screening system. Marked rhizobia bearing the plasmid could be inoculated onto plants in a mixed rhizobial population, identified by fluorescence, and recovered live from nodules for further analysis.

Golden Gate Level 2 Cloning Vectors
-----------------------------------

We designed our level 2 vectors to be directly compatible with the methods and plasmids described in the MoClo system by [@B31] for construction of level 2 plasmids containing multiple transcriptional units. In the MoClo system, multigene constructs are constructed by assembling transcriptional units by Golden Gate level 1 cloning reaction into level 1 shuttle vectors that dictate the final position in a level 2 construct. Transcriptional units are then combined with an endlinker using a Golden Gate level 2 cloning reaction with BpiI. Endlinkers can either terminate the construct or provide cloning sites for iterative rounds of cloning ([@B31]). To demonstrate the flexibility of the assembly system we have designed and constructed a level 2 destination vector, pOGG216 (Figure [5A](#F5){ref-type="fig"}). Vector pOGG216 was made by a one-pot reaction for vector assembly (Esp3I and ligase) with the following modules (listed in Table [2](#T2){ref-type="table"}): position 1; level 2 cloning site from pOGG006, position 2; tetracycline-resistance module from pOGG042, position 3; pBBR1 origin from pOGG011 and an appropriate Endlinker (ELT3) from pOGG013. The level 2 cloning site encodes an operon for canthaxanthin biosynthesis that is replaced upon successful level 2 cloning and allows identification of successful clones based on an orange to white colony color phenotype.

![**(A)** Schematic map of pOGG216 level 2 broad-host range, medium copy number vector constructed with BEVA for multi-gene expression. **(B)** Schematic map of dual reporter plasmid pOPS0754 which encodes IPTG-inducible sfGFP cloned in Forward Position 1 and constitutively mCherry cloned in Forward Position 2. **(C,E,G)** Green fluorescence detection (scale, 5,000--31,000). **(D,F)** Red fluorescence detection (scale, 3,000--29,000 cps). **(C,D)** Rlv3841 without fluorescence. Rlv3841\[pOPS0754\] expressing IPTG-inducible sfGFP grown in media **(E)** containing 0.5 mM IPTG or **(G)** without IPTG. **(F)** Rlv3841\[pOPS0754\] with constitutively expressed mCherry.](fmicb-09-03345-g005){#F5}

Gene Expression Using Vector pOGG216
------------------------------------

To validate the performance of vector pOGG216, a level 2 cloning reaction was performed (one-pot reaction with BpiI and ligase) to assemble two ORFs encoding IPTG-inducible sfGFP and constitutively expressed to construct pOPS0754 (Figure [5B](#F5){ref-type="fig"}), Assembly in *E. coli* of the final dual reporter plasmid pOPS0754 was very efficient (\>90% correct constructs, the same as described by [@B31]. The plasmid was conjugated into Rlv3841 and the observed green and red fluorescence from this dual reporter plasmid is shown in Figure [5](#F5){ref-type="fig"}. Significant green and red fluorescence were observed in Rlv3841\[pOPS0754\] compared to the Rlv3841 wild-type (Figures [5C](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"} and Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). GFP fluorescence of Rlv3841\[pOPS0754\] was dependant on growth in the presence of IPTG (Figures [5E,G](#F5){ref-type="fig"}).

Conclusion
==========

In conclusion, the BEVA system we describe has proved to be robust and flexible for creating new bacterial vectors. The modular vectors we constructed with this system behaved consistently well in the Gram-negative bacteria tested (*E. coli* and *R. leguminosarum*), and demonstrated stability in the environments tested (rhizosphere and nitrogen-fixing root nodules formed by symbiotic bacteria) when engineered to contain the stability accessory module (*par* genes). The BEVA vectors for use in Golden Gate cloning (level 1: pOGG005, pOGG024 and pOGG026, and level 2: pOGG216) have been made available through Addgene (Table [3](#T3){ref-type="table"}). While these vectors are useful for cloning and gene expression in *R. leguminosarum*, the major advantage of the modular system described here is its flexibility. The ability to rapidly assemble BEVA vectors with unique features, specifically suited to a specific purpose, e.g., alternative antibiotic resistance modules to avoid conflict with other markers, or to alter the origin of replication to avoid plasmid incompatibility has enormous applications for those working in many different areas. Rapid assembly of new BEVA vectors from such a bank of parts in this way offers a quick and economical option for construction of new vectors, not only for bacteria, as the system could be expanded to include parts for plant transformation or replication and maintenance in fungi.

Materials and Methods {#s1}
=====================

Bacterial Media and Growth Conditions
-------------------------------------

Bacterial strains and plasmids used in this study are listed in Table [3](#T3){ref-type="table"}. *E. coli* strains were grown in liquid or on solid Luria--Bertani (LB) medium ([@B23]) at 37°C, supplemented with antibiotics at the following concentrations: tetracycline (10 μg ml^-1^), gentamicin (10 μg ml^-1^), kanamycin (20 μg ml^-1^) or spectinomycin (100 μg ml^-1^). Rhizobial strains were grown on tryptone yeast (TY) agar or broth ([@B2]) or universal minimal salts (UMS) ([@B21]) at 28°C. Antibiotics were added to TY when necessary at the following concentrations: streptomycin (500 μg ml^-1^), tetracycline (5 μg ml^-1^), gentamicin (20 μg ml^-1^), rifampicin (50 μg ml^-1^), and neomycin (40 μg ml^-1^).

Plasmids were transferred into wild-type (Rlv3841 and R. *tropici* CIAT899 backgrounds by triparental mating according to [@B10].

Golden Gate Vector Assembly, Level 1 and Level 2 Cloning
--------------------------------------------------------

Vector assembly was performed in a thermocycler in 15 μl total volume, containing 40 fmols of each cloned module (position or ELT) (which equates to approximately 1 μl of 4 Kb plasmid at 100 ng μl^-1^), 1.5 μl Bovine Serum Albumin (1 mg ml^-1^), 1 μl Esp3I FD (Thermo Scientific), 1 μl concentrated T4 DNA Ligase (New England Biolabs), 1.5 μl T4 DNA Ligase buffer (New England Biolabs) with water to 15 μl. Tubes were prepared on ice before 25 cycles: 3 min at 37°C then 4 min at 16°C, followed by 5 min at 50°C and 5 min at 80°C. Samples were cooled on ice and 1 μl was transformed into 10 μl of *E. coli* competent cells (Bioline Gold) by heat shock for 1 min at 42°C ([@B8]) and plated onto LB with appropriate antibiotics (for pOGG024 selection was for gentamicin-resistance, for pOGG026 for kanamycin resistance and for pOGG216 for tetracycline resistance) and X-gal at 40 μg ml^-1^. Several colonies showing the correct color, i.e., blue for pOGG024 and pOGG026 (level 1) vector assembly (color is conferred by the presence of *lacZα* in the cloning site) and orange for pOGG216 (level 2) (conferred by a canthaxanthin biosynthesis cluster in the cloning site) ([@B31]), were screened by plasmid restriction digest and sequencing to verify correct constructs. Correct plasmid assembly was observed at very high frequencies and comparable to those described for Golden Gate cloning reactions ([@B31]).

Level 1 cloning was performed as described above, except BsaI FD (Thermo Scientific) replaced Esp3I. For level 2 cloning, BpiI (Thermo Scientific) was used instead of Esp3I. Transformation was performed as described above and colonies showing the correct color based on the replacement of modules in the vector cloning sites (blue to white for level 1 and orange to blue or white for level 2) were screened by plasmid restriction digest and sequencing to verify correct constructs.

The plasmid pOPS0359 was assembled by a Golden Gate level 1 cloning reaction performed with the following components (listed in Table [2](#T2){ref-type="table"}) in a one-pot reaction (digestion with BsaI and ligation): vector; pOGG024, PU module; *Sinorhizobium meliloti* taurine promoter from pOGG041, SC module; sfGFP from pOGG037, T module; T-pharma terminator from pOGG003.

The plasmid pOPS0253 was constructed from the following (listed in Table [3](#T3){ref-type="table"}): vector; pOGG026, PU module; Rlv3841P*nifH* from pOGG082, SC module; *gusA* from pOGG083; T module; T-pharma terminator from pOGG003. Plasmids pOPS0254 and pOPS0379 are identical to pOPS0253, except that the SC modules are *celB* from pOGG050 and sfGFP from pOGG037, rather than *gusA*. Positive controls were constructed with the constitutive neomycin cassette promoter (pNptII) from pOGG001 (PU) instead of the Rlv3841P*nifH* from pOGG082 resulting in the plasmids.

The dual reporter plasmid pOPS0754 was constructed using the following parts in a level 2 Golden Gate cloning reaction: level 2 vector pOGG216, forward position 1 from pOGG202, forward position 2 from pOGG203 and level 2 Endlinker ELB-2 from pOGG056. Plasmid pOGG202 (clone of a level 1 unit which encodes IPTG-inducible sfGFP) was constructed by combining the following: forward position 1 shuttle vector pL1V-F1 pOGG021, PU module pLac from pOGG031, SC module sfGFP from pOGG037 together with T module T-pharma from pOGG003. Plasmid pOGG203 (clone of a level 1 unit which encodes a constitutively expressed mCherry) was assembled by combining the following: forward position 2 shuttle vector pL1V-F2 pOGG054, PU module pNeo from pOGG001, SC module mCherry from EC15071 and T module T-pharma from pOGG003.

Plant Growth
------------

*Pisum sativum* (pea) and *Phaseolus vulgaris* (bean) seeds were surface sterilized by immersion in 95% ethanol for 0.5 min, followed by washing with sterile water. Seeds were then immersed in 2% sodium hypochlorite for 5 min. After washing the seeds five times with sterile water, they were placed onto 1% agar (DWA) plates in the dark at room temperature for 4--5 days to allow germination. Pea seedlings were placed in sterile 1-liter pots with medium vermiculite and supplied with 400 ml nitrogen-free rooting solution ([@B21]). In the case of beans, seedlings were placed in sterile 2-liter pots with fine vermiculite and supplied with 800 ml nitrogen-free rooting solution, ([@B4]). Plants were inoculated at approximately 10^7^ cfu of rhizobia per pot and plants without inoculation were grown as a control. Plants were grown (random positioning of pots) in a controlled growth chamber at 21°C, 16-h/8-h day/night cycle.

Enzyme Activity in Nodules
--------------------------

Pea plants were harvested 21 dpi and bean plants 42 dpi. Roots were stained with Magenta-glcA (5-bromo-6-chloro-3-indolyl-β-D-glucuronide acid, 200 μg ml^-1^) for plants nodulated with strain Rlv3841\[pOPS0253\] containing the ß-glucuronidase gene (*gusA*). For plants nodulated with rhizobial strains Rlv3841\[pOPS0254\] and CIAT 899\[pOPS0254\] containing ß-glucosidase gene (*celB)*, roots were stained with X-gal (5-bromo-4-chloro-3-indolyl- β-D-galactopyranoside, 250 μg ml^-1^) after thermal treatment at 70°C for 30 min to destroy endogenous β-galactosidases ([@B26]).

Measurement of Bacterial Growth and GFP Assays
----------------------------------------------

Measurements of bacterial growth OD~595~ and GFP fluorescence (excitation 485 nm and emission 520 nm) were performed with a FLUOstar OMEGA (Lite) photometer. Rhizobia were grown on TY agar slopes with appropriate antibiotics for 3 days, washed with UMS and resuspended in UMS with 30 mM pyruvate and 10 mM NH~4~Cl (as carbon and nitrogen sources) at an OD~595~ of 0.1 at the start of the assay. Assays were performed in 24-well clear bottom micro-titre plates with 400 μl culture. Cells were incubated at 28°C with orbital shaking at 500 RPM for 48 h with measurement of optical density and fluorescence every 30 min.

Microscopy
----------

Photographs were taken using a dissecting microscope (Leica M165 FC) with a Leica DFC310 FX digital camera accompanying software (LAS v4.5). Visible light, cherry and GFP filters were used.

Image Acquisition for Green and Red Fluorescence Expression
-----------------------------------------------------------

NightOWL camera (Berthold Technologies) was used for imaging fluorescence of bacteria grown on agar plates or plant roots. Each CCD image consisted of an array 1,024 by 1,024 pixels, and after acquisition, images were postprocessed for cosmic suppression and background correction. Fluorescence CCD images were acquired with a Ring-light epi illumination accessory exposed for 1 s and special filters have to be used. Filter used for GFP quantification at excitation wavelength 475/20 and emission wavelength 520/10 nm. Filter used for mCherry quantification at excitation wavelength 550/10 and emission wavelength 620/10 nm. Images were analyzed with the imaging software IndiGO (Berthold Technologies).
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Dissecting microscope image of single colonies formed by Rlv3841\[pOPS0754\]. **(A)** Bright-field and fluorescence detection with **(B)** GFP filter and **(C)** red filter.
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Click here for additional data file.
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